Thrombolysis Using Tissue Plasminogen Activator: Experience from a Critical Care Setting
- 97 Downloads
To describe the experience of thrombolysis using tissue plasminogen activator (tPA) in critically ill children admitted to the pediatric intensive care unit (PICU), retrospective review of medical records of all children (1 month–16 years), who were admitted in PICU since January 2014 to December 2017 and received systemic tPA for thrombolysis was done. Data was collected on a structured proforma and included thrombus location, tPA dose and duration, outcome (resolution, survival) and complications (bleeding). Total 9 patients (7 males, 2 females) received systemic tPA therapy for thrombolysis with mean age of 74.64 ± 69.58 months. Two patients had thrombus in femoral artery, 3 in IVC and 4 had intra-cardiac thrombosis. Median number of doses was 2 with a range of 1–5 doses. Complete resolution of the clot was noted in all except one patient. A standard starting dose of 0.01 mg/kg/h was used in all patients. Only one patient developed melena after TPA therapy which self-resolved. Systemic tPA therapy was very safe in pediatric critically ill patients and was effective for thrombolysis and did not show any adverse effects in children with varying underlying diagnosis.
KeywordsSystemic tPA Children Thrombolysis
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
Aga Khan University 4893-PED-ERC-17.
- 1.Chan AK, Monagle P (2012) Updates in thrombosis in pediatrics: where are we after 20 years? Hematol Am Soc Hematol Educ Program 2012:439–443Google Scholar
- 8.Ansah DA, Patel KN, Montegna L, Nicholson GT, Ehrlich AC, Petit CJ (2016) Tissue plasminogen activator use in children: bleeding complications and thrombus resolution. J Pediatr 171(67–72):e1–e2Google Scholar
- 9.Monagle P, Chan AK, Goldenberg NA, Ichord RN, Journeycake JM, Nowak-Gottl U et al (2012) Antithrombotic therapy in neonates and children: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e737S–e801SCrossRefGoogle Scholar